References
- Headache Classification Committee of the International Headache Society (IHS) . The international classification of headache disorders (beta version). Cephalalgia33(9), 629–808 (2013).
- May A , SchulteLH. Chronic migraine: risk factors, mechanisms and treatment. Nat. Rev. Neurol.12(8), 455–464 (2016).
- Torres-Ferrús M , UrsittiF , AlpuenteAet al. From transformation to chronification of migraine: pathophysiological and clinical aspects. J. Headache Pain21(1), 42 (2020).
- Headache Classification Committee of the International Headache Society (IHS) . The International Classification of Headache Disorders, 3rd edition. Cephalalgia38(1), 1–211 (2018).
- Agostoni EC , BarbantiP , CalabresiPet al. Current and emerging evidence-based treatment options in chronic migraine: a narrative review. J. Headache Pain20(1), 92 (2019).
- Moisset X , PereiraB , Ciampide Andrade D , FontaineD , Lantéri-MinetM , MawetJ. Neuromodulation techniques for acute and preventive migraine treatment: a systematic review and meta-analysis of randomized controlled trials. J. Headache Pain21(1), 142 (2020).
- Buse DC , ManackAN , FanningKMet al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache52(10), 1456–1470 (2012).
- Finocchi C , StradaL. Sex-related differences in migraine. Neurol. Sci.35(Suppl. 1), 207–213 (2014).
- Lipton RB , StewartWF , DiamondS , DiamondML , ReedM. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache41(7), 646–657 (2001).
- Manack AN , BuseDC , LiptonRB. Chronic migraine: epidemiology and disease burden. Curr. Pain Headache Rep.15(1), 70–78 (2011).
- Schwedt TJ . Chronic migraine. BMJ [Internet]348 (2014). https://www.bmj.com/content/348/bmj.g1416
- Scher AI , StewartWF , RicciJA , LiptonRB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain106(1–2), 81–89 (2003).
- Ferrari A , BaraldiC , SternieriE. Medication overuse and chronic migraine: a critical review according to clinical pharmacology. Expert Opin. Drug Metab. Toxicol.11(7), 1127–1144 (2015).
- Lipton RB , FanningKM , SerranoD , ReedML , CadyR , BuseDC. Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology84(7), 688–695 (2015).
- Lipton RB , MunjalS , BuseDC , FanningKM , BennettA , ReedML. Predicting inadequate response to acute migraine medication: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache56(10), 1635–1648 (2016).
- De Felice M , OssipovMH , PorrecaF. Update on medication-overuse headache. Curr. Pain Headache Rep.15(1), 79–83 (2011).
- Meng ID , DodickD , OssipovMH , PorrecaF. Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies. Cephalalgia31(7), 851–860 (2011).
- [No authors listed]. The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice. Headache59(1), 1–18 (2019).
- Nierenburg HDC , AilaniJ , MalloyM , SiavoshiS , HuNN , YusufN. Systematic review of preventive and acute treatment of menstrual migraine. Headache55(8), 1052–1071 (2015).
- Nierenburg H , VieiraJR , LevNet al. Remote electrical neuromodulation for the acute treatment of migraine in patients with chronic migraine: an open-label pilot study. Pain Ther.9, 531–543 (2020).
- Bigal ME , SerranoD , BuseD , ScherA , StewartWF , LiptonRB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache48(8), 1157–1168 (2008).
- Sun-Edelstein C , RapoportAM. Update on the pharmacological treatment of chronic migraine. Curr. Pain Headache Rep.20(1), 6 (2016).
- Ho TW , EdvinssonL , GoadsbyPJ. CGRP and its receptors provide new insights into migraine pathophysiology. Nat. Rev. Neurol.6(10), 573–582 (2010).
- Hershey AD , IrwinS , RabanyLet al. Comparison of remote electrical neuromodulation (REN) and standard-care medications for acute treatment of migraine in adolescents: a post-hoc analysis. Pain Medicine [Internet] doi: 10.1093/pm/pnab197 (2021). https://doi.org/10.1093/pm/pnab197
- Lipton RB , SilbersteinSD. Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention. Headache55(Suppl. 2), 103–122 (2015).
- Grosberg B , LinT , VizelM , SchimJ. Remote electrical neuromodulation for the acute treatment of chronic migraine 2007. Neurology [Internet]96(Suppl. 15), (2021). https://n.neurology.org/content/96/15_Supplement/2007
- Ailani J , BurchRC , RobbinsMS. Board of Directors of the American Headache Society. The American Headache Society Consensus Statement: update on integrating new migraine treatments into clinical practice. Headache61(7), 1021–1039 (2021).
- Rapoport AM , LinT , TepperSJ. Remote electrical neuromodulation (REN) for the acute treatment of migraine. Headache60(1), 229–234 (2020).
- Rapoport AM , LinT. Device profile of the Nerivio™ for acute migraine treatment: overview of its efficacy and safety. Expert Rev. Med. Devices16(12), 1017–1023 (2019).
- Yarnitsky D , VolokhL , IroniAet al. Nonpainful remote electrical stimulation alleviates episodic migraine pain. Neurology88(13), 1250–1255 (2017).
- Hershey AD , LinT , GruperYet al. Remote electrical neuromodulation for acute treatment of migraine in adolescents. Headache61(2), 310–317 (2020).
- Yarnitsky D , DodickDW , GrosbergBMet al. Remote electrical neuromodulation (REN) relieves acute migraine: a randomized, double-blind, placebo-controlled, multicenter trial. Headache59(8), 1240–1252 (2019).
- Daniel O , SharonR , TepperSJ. A device review of Relivion®: an external combined occipital and trigeminal neurostimulation (eCOT-NS) system for self-administered treatment of migraine and major depressive disorder. Expert Rev. Med Devices18(4), 333–342 (2021).
- Marmura MJ , LinT , HarrisD , IroniA , RosenNL. Incorporating remote electrical neuromodulation (REN) into usual care reduces acute migraine medication use: an open-label extension study. Front. Neurol. [Internet]11 (2020). https://www.frontiersin.org/articles/10.3389/fneur.2020.00226/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Neurology&id=496800
- Rapoport AM , BonnerJH , LinTet al. Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications. J. Headache Pain20(1), 83 (2019).
- Tepper SJ , LinT , MontalT , IroniA , DoughertyC. Real-world experience with remote electrical neuromodulation in the acute treatment of migraine. Pain Med. [Internet]https://academic.oup.com/painmedicine/advance-article/doi/10.1093/pm/pnaa299/5906300
- Nierenburg H , RabanyL , LinTet al. Remote electrical neuromodulation (REN) for the acute treatment of menstrual migraine: a retrospective survey study of effectiveness and tolerability. Pain Ther [Internet] (2021). https://doi.org/10.1007/s40122-021-00276-7